As a pharmacist and manufacturer, I classify this as an anti-inflammatory and anti-edemic enzyme. It is rarely used as a standalone treatment; rather, it is a powerful “adjunct” that enhances the efficacy of antibiotics and NSAIDs by breaking down the physical barriers of inflammation.

Primary Clinical Uses

• Reduction of Edema and Swelling: Used post-surgery or after traumatic injury (like sprains or fractures) to resolve fluid accumulation and swelling.

• Respiratory Conditions: Acts as a mucolytic. It breaks down the protein structure of thick mucus and sputum in conditions like Bronchitis, Asthma, and Sinusitis, making it easier to cough up.

• Dental Inflammation: Frequently prescribed after tooth extractions or during periodontitis to manage gum swelling.

• Surgical Recovery: Used in ENT (Ear, Nose, Throat) surgeries to reduce post-operative inflammation of the mucous membranes.

• Fibrocystic Breast Disease: Occasionally used to reduce pain and swelling in breast engorgement.

Mechanism of Action: Proteolysis & Biofilm Disruption

Serratiopeptidase works by specifically targeting non-living tissue and inflammatory by-products.

Fibrinolytic Activity: It breaks down fibrin, a protein involved in blood clotting and the formation of the “inflammatory wall.” By dissolving this, it allows the body’s natural healing fluids to circulate better.

Thinning of Fluids: It thins the fluids around the injury site, facilitating their drainage and reducing the pressure that causes pain.

Inhibition of Pain Mediators: It inhibits the release of pain-inducing amines like Bradykinin, which directly reduces the sensation of pain.

Biofilm Penetration: In a B2B clinical context, its most impressive feat is breaking down bacterial biofilms. This “clears the path” for antibiotics to reach the bacteria more effectively.

The Manufacturer’s Perspective: Technical & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Serratiopeptidase 5 mg (or 10,000 units) requires extreme technical care:

• Enteric Coating is Mandatory: This is the most critical technical point. Serratiopeptidase is a protein and would be instantly destroyed by stomach acid ($HCl$). To ensure it reaches the small intestine for absorption, your tablets must be enteric-coated. Promoting this “Acid-Resistant Coating” on your digital platform is essential for professional credibility.

• Activity vs. Weight: As a manufacturer, you know we measure this enzyme in IU (International Units) or Serratiopeptidase Units (SPU) rather than just mg. For export, 5 mg typically corresponds to 10,000 units.

• Temperature Sensitivity: Being an enzyme, it is thermolabile. During manufacturing and shipping from Mumbai, maintaining a temperature below 25°C is vital to prevent denaturing.

• Dossier Support: We provide full CTD/eCTD Dossiers to support international registration, especially in markets like Southeast Asia and the Middle East where enzyme therapy is highly popular.